What's next for Wesfarmers shares after cashing out $700 million from Coles?

What will Wesfarmers do with its $700 million windfall?

| More on:
A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Wesfarmers and Coles have a long history of cooperation
  • Wesfarmers first acquired Coles back in 2007 but divested most of its stake in the 2018 spinoff
  • Now, it looks like Wesfarmers may have sold its last remaining shares

Well, a 16-year partnership between two of the largest and most famous companies on the S&P/ASX 200 Index (ASX: XJO) seems to have finally come to an end this week. We are, of course, talking about Wesfarmers Ltd (ASX: WES) and Coles Group Ltd (ASX: COL) shares.

The partnership between these two giants of the ASX (and the Australian retail landscape) began back in 2007. That was when Wesfarmers sensationally acquired the Coles business in its entirety, paying $22 billion for the business in what was one of the largest corporate takeovers in history at the time.

Wesfarmers ran Coles out of its own stable for the next 11 years before announcing a spinoff in 2018. Five years ago, Coles was floated under its own steam on the ASX, with Wesfarmers shareholders receiving one share of the newly-listed Coles for every share owned at the time.

Wesfarmers shares and their history with Coles

However, under the deal, Wesfarmers retained a significant portion of Coles shares, worth around 15% of the company.

Over the years, Wesfarmers has steadily sold off its remaining Coles shares though. By the end of last week, the company had just 2.8% of Coles remaining on its books.

But Wesfarmers has cashed out of Coles completely at last. A brief statement on its website confirms the sale, with no further detail.

Although, according to reporting in Reuters this week, the sale figure is placed at $18.50 per share, which would mean the sale had a value of around $688 million.

So now that Wesfarmers has closed this very long chapter in its history, what might the conglomerate have in mind for this cash windfall?

Wesfarmers is a company with a long pattern of mergers, acquisitions and spinoffs. It was only in 2021 that it made its largest recent acquisition, taking total control of pharmacy operator API, which is well known for its Priceline pharmacy chain.

Before that, the company made a venture into the lithium industry with its acquisition of Kidman Resources in 2019. It has since expanded its lithium exposure with its Covalent Lithium business and flagship Mt Holland Project.

What will the conglomerate spend its Coles cash on?

But Wesfarmers has made no official indications of what its next acquisition might be. In its most recent earnings report from February, the company stated that its outlook involved the following:

The Group maintains its long-term focus and continues to invest in strengthening its existing operations, renewing the portfolio and developing platforms for long-term growth.

Recent investments enable Wesfarmers to take advantage of growing consumer and industrial demand in the health and critical minerals sectors.

It's possible Wesfarmers will use the proceeds from its Coles sale to make further investments into its online-facing OneDigital division. This includes Wesfarmers' catch.com.au business, as well as the OnePass and OneData programs. This division of Wesfarmers is growing rapidly, with more than 1.5 million digital interactions per month reported in February, up from half a million a month in FY 2019.

But the division is still losing Wesfarmers money on the bottom line, contributing an earnings loss of $108 million for the half-year ending 31 December 2022.

The company could also have plans to use the proceeds to invest back into its growing Health division, or else expand further into lithium or battery technologies, as per its outlook discussed above.

Whatever Wesfarmers has planned for its extra cash, it's certainly a big week for both Coles and Wesfarmers as one of the most significant corporate partnerships in Australian history closes its final chapter.

Motley Fool contributor Sebastian Bowen has positions in Wesfarmers. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Coles Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

A silhouette shot of two business man shake hands in a boardroom setting with light coming from full length glass windows beyond them.
Mergers & Acquisitions

Rio Tinto share price rises on $10b Arcadium Lithium takeover deal

Management believes the deal makes it a global leader in energy transition commodities.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Mergers & Acquisitions

Arcadium Lithium shares rocket 46% on Rio Tinto takeover approach

The mining giant could soon become the third largest lithium supplier.

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Platinum shares slump despite Regal takeover update

Could a takeover deal be getting closer? Let's find out.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Sigma shares up 25% in 2 days as Chemist Warehouse merger looks set

The deal continues to create tailwinds for Sigma shares.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Small Cap Shares

Which small cap ASX stock is jumping 20% after receiving a takeover offer?

This tech stock could be heading to the NASDAQ after receiving a takeover offer.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Guess which ASX 200 healthcare stock is up 12% on big Chemist Warehouse news

Investors appear to believe this news could be a sign that the deal will go ahead.

Read more »

Happy woman holding white house model in hand and pointing to it with a pen.
Mergers & Acquisitions

REA share price charges higher on big Rightmove news

It wasn't fourth time lucky for the realestate.com.au operator.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Financial Shares

Platinum shares fall after rejecting Regal Partners takeover offer

The fund manager believes the offer undervalues the company.

Read more »